These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14624311)

  • 1. In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances.
    Ishii R; Shimizu M; Nakagawa Y; Shimizu K; Tanaka S; Takahashi H
    Cancer Immunol Immunother; 2004 May; 53(5):383-90. PubMed ID: 14624311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cells.
    Harimoto H; Shimizu M; Nakagawa Y; Nakatsuka K; Wakabayashi A; Sakamoto C; Takahashi H
    Immunol Cell Biol; 2013 Oct; 91(9):545-55. PubMed ID: 24018532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells.
    Nakatsuka K; Sugiyama H; Nakagawa Y; Takahashi H
    J Hepatol; 1999 Jun; 30(6):1119-29. PubMed ID: 10406192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
    Petersen TR; Sika-Paotonu D; Knight DA; Simkins HM; Hermans IF
    PLoS One; 2011 Mar; 6(3):e17657. PubMed ID: 21483862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
    Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.
    Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML
    J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.
    Ontiveros F; Wilson EB; Livingstone AM
    Immunology; 2011 Apr; 132(4):549-58. PubMed ID: 21255009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.
    Rubin B; Riond J; Courtiade L; Roullet N; Gairin JE
    Cancer Immun; 2008 Sep; 8():14. PubMed ID: 18783178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
    Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
    Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell development in mice expressing CD1d directed by a classical MHC class II promoter.
    Forestier C; Park SH; Wei D; Benlagha K; Teyton L; Bendelac A
    J Immunol; 2003 Oct; 171(8):4096-104. PubMed ID: 14530331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
    Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
    Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
    Xu H; Chun T; Colmone A; Nguyen H; Wang CR
    J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
    Paglia P; Chiodoni C; Rodolfo M; Colombo MP
    J Exp Med; 1996 Jan; 183(1):317-22. PubMed ID: 8551239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.